• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭患者的冠状动脉微血管功能障碍:HFrEF 与 HFpEF 患者的特征模式。

Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF.

机构信息

Cardiovascular Center Aalst, OLV Hospital, Belgium (P.P., E.G., M.B., D.T.B., K.B., C.D.C., M.S., A.L., G.E., D.F., A.M., L.D., M.P., B.D.B., J.B., M.V.).

Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy (P.P., M.B., D.T.B., C.D.C., A.L., G.E., D.F.).

出版信息

Circ Heart Fail. 2024 Jan;17(1):e010805. doi: 10.1161/CIRCHEARTFAILURE.123.010805. Epub 2023 Dec 18.

DOI:10.1161/CIRCHEARTFAILURE.123.010805
PMID:38108151
Abstract

BACKGROUND

Coronary microvascular dysfunction (CMD) is involved in heart failure (HF) onset and progression, independently of HF phenotype and obstructive coronary artery disease. Invasive assessment of CMD might provide insights into phenotyping and prognosis of patients with HF. We aimed to assess absolute coronary flow, absolute microvascular resistance, myocardial perfusion, coronary flow reserve, and microvascular resistance reserve in patients with HF with preserved ejection fraction and HF with reduced ejection fraction (HFrEF).

METHODS

Single-center, prospective study of 56 consecutive patients with de novo HF with nonobstructive coronary artery disease divided into HF with preserved ejection fraction (n=21) and HFrEF (n=35). CMD was invasively assessed by continuous intracoronary thermodilution and defined as coronary flow reserve <2.5. Left ventricular and left anterior descending artery-related myocardial mass was quantified by echocardiography and coronary computed tomography angiography. Myocardial perfusion (mL/min per g) was calculated as the ratio between absolute coronary flow and left anterior descending artery-related mass.

RESULTS

Patients with HFrEF showed a higher left ventricular and left anterior descending artery-related myocardial mass compared with HF with preserved ejection fraction (<0.010). Overall, 52% of the study population had CMD, with a similar prevalence between the 2 groups. In HFrEF, CMD was characterized by lower absolute microvascular resistance and higher absolute coronary flow at rest (functional CMD; =0.002). CMD was an independent predictor of a lower rate of left ventricular reverse remodeling at follow-up. In patients with HF with preserved ejection fraction, CMD was mainly due to higher absolute microvascular resistance and lower absolute coronary flow during hyperemia (structural CMD; ≤0.030).

CONCLUSIONS

Continuous intracoronary thermodilution allows the definition and characterization of patterns with distinct CMD in patients with HF and could identify patients with HFrEF with a higher rate of left ventricular reverse remodeling at follow-up.

摘要

背景

冠状动脉微血管功能障碍(CMD)与心力衰竭(HF)的发生和进展有关,与 HF 表型和阻塞性冠状动脉疾病无关。CMD 的侵入性评估可能有助于了解 HF 患者的表型和预后。我们旨在评估射血分数保留的心力衰竭(HFpEF)和射血分数降低的心力衰竭(HFrEF)患者的绝对冠状动脉血流、绝对微血管阻力、心肌灌注、冠状动脉血流储备和微血管阻力储备。

方法

对 56 例新发非阻塞性冠状动脉疾病的 HF 患者进行单中心前瞻性研究,分为 HFpEF(n=21)和 HFrEF(n=35)。通过连续冠状动脉内热稀释法评估 CMD,并将冠状动脉血流储备<2.5 定义为 CMD。通过超声心动图和冠状动脉计算机断层血管造影术定量评估左心室和左前降支相关心肌质量。心肌灌注(mL/min/g)计算为绝对冠状动脉血流与左前降支相关质量的比值。

结果

与 HFpEF 相比,HFrEF 患者的左心室和左前降支相关心肌质量更高(<0.010)。总的来说,52%的研究人群存在 CMD,两组之间的患病率相似。在 HFrEF 中,CMD 表现为静息时较低的绝对微血管阻力和较高的绝对冠状动脉血流(功能性 CMD;=0.002)。CMD 是随访时左心室反向重构率较低的独立预测因素。在 HFpEF 患者中,CMD 主要是由于充血时绝对微血管阻力较高和绝对冠状动脉血流较低(结构性 CMD;≤0.030)。

结论

连续冠状动脉内热稀释法可定义和描述 HF 患者中不同类型的 CMD,并可识别随访时左心室反向重构率较高的 HFrEF 患者。

相似文献

1
Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF.心力衰竭患者的冠状动脉微血管功能障碍:HFrEF 与 HFpEF 患者的特征模式。
Circ Heart Fail. 2024 Jan;17(1):e010805. doi: 10.1161/CIRCHEARTFAILURE.123.010805. Epub 2023 Dec 18.
2
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭患者中的冠状动脉疾病和冠状动脉微血管功能障碍的患病率。
JAMA Cardiol. 2021 Oct 1;6(10):1130-1143. doi: 10.1001/jamacardio.2021.1825.
3
Myocardial contrast echocardiography evaluation of coronary microvascular dysfunction to Predict MACEs in patients with heart failure with preserved ejection fraction follow-up.心肌声学造影评估冠状动脉微血管功能障碍预测射血分数保留的心力衰竭患者的主要不良心血管事件的随访。
BMC Cardiovasc Disord. 2024 Sep 18;24(1):496. doi: 10.1186/s12872-024-04173-7.
4
Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study.冠状动脉微血管功能障碍与射血分数保留的心力衰竭患者心力衰竭住院和死亡的相关性:PROMIS-HFpEF 研究的随访。
J Card Fail. 2020 Nov;26(11):1016-1021. doi: 10.1016/j.cardfail.2020.08.010. Epub 2020 Aug 23.
5
Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction.冠状动脉微血管功能障碍与射血分数保留心力衰竭患者的运动血流动力学异常有关。
Eur J Heart Fail. 2021 May;23(5):765-772. doi: 10.1002/ejhf.2010. Epub 2020 Oct 7.
6
Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve.2型糖尿病患者的微血管功能障碍:绝对冠状动脉血流和微血管阻力储备的有创评估
Front Cardiovasc Med. 2021 Oct 19;8:765071. doi: 10.3389/fcvm.2021.765071. eCollection 2021.
7
Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.左心房容积和左心室质量指数在射血分数保留和降低的心力衰竭中的变化。
ESC Heart Fail. 2021 Aug;8(4):2458-2466. doi: 10.1002/ehf2.13366. Epub 2021 Jun 4.
8
Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.厘清冠状动脉微血管功能障碍与射血分数保留型心力衰竭之间的病理生理联系。
Eur Heart J. 2021 Nov 14;42(43):4431-4441. doi: 10.1093/eurheartj/ehab653.
9
Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study.冠状动脉疾病和射血分数保留的心力衰竭:ARIC 研究。
J Am Heart Assoc. 2022 Sep 6;11(17):e021660. doi: 10.1161/JAHA.121.021660. Epub 2022 Aug 24.
10
Prevalence and Long-Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction.心力衰竭伴射血分数保留与降低的女性和男性患者行冠状动脉旁路移植术的患病率和长期生存情况。
J Am Heart Assoc. 2018 Jun 16;7(12):e008902. doi: 10.1161/JAHA.118.008902.

引用本文的文献

1
Coronary microvascular disease in heart failure with preserved ejection fraction.射血分数保留的心力衰竭中的冠状动脉微血管疾病
Physiol Rep. 2025 Aug;13(16):e70521. doi: 10.14814/phy2.70521.
2
Exercise capacity in heart failure: a systematic review and meta-analysis of HFrEF and HFpEF disparities in VOpeak and 6-minute walking distance.心力衰竭中的运动能力:射血分数降低的心力衰竭(HFrEF)和射血分数保留的心力衰竭(HFpEF)在峰值摄氧量(VOpeak)和6分钟步行距离方面差异的系统评价与荟萃分析
Eur Heart J Open. 2025 May 14;5(3):oeaf055. doi: 10.1093/ehjopen/oeaf055. eCollection 2025 May.
3
Vascular (dys)function in the failing heart.
衰竭心脏中的血管(功能失调)功能
Nat Rev Cardiol. 2025 Jun 22. doi: 10.1038/s41569-025-01163-w.
4
Resting coronary flow and long-term clinical outcomes in dilated cardiomyopathy.扩张型心肌病患者的静息冠脉血流与长期临床结局
Int J Cardiovasc Imaging. 2025 May 29. doi: 10.1007/s10554-025-03432-8.
5
Factors Predicting Myocardial Recovery After Hospitalization for De Novo Heart Failure with Reduced Left Ventricular Ejection Fraction: Results from the COMFE Registry.左心室射血分数降低的初发心力衰竭患者住院后心肌恢复的预测因素:COMFE注册研究结果
Biomedicines. 2025 May 8;13(5):1143. doi: 10.3390/biomedicines13051143.
6
Cardiovascular dysfunction and altered lysosomal signaling in a murine model of acid sphingomyelinase deficiency.酸性鞘磷脂酶缺乏小鼠模型中的心血管功能障碍和溶酶体信号改变
J Mol Med (Berl). 2025 May;103(5):599-617. doi: 10.1007/s00109-025-02542-z. Epub 2025 Apr 15.
7
Cardiovascular Dysfunction and Altered Lysosomal Signaling in a Murine Model of Acid Sphingomyelinase Deficiency.酸性鞘磷脂酶缺乏小鼠模型中的心血管功能障碍与溶酶体信号改变
Res Sq. 2025 Mar 20:rs.3.rs-5154105. doi: 10.21203/rs.3.rs-5154105/v1.
8
The Novel A-Flux Coronary Sinus Reducer Normalizes Coronary Microvascular Function in a Persistently Symptomatic Patient.新型A-Flux冠状静脉窦减压器使一名持续有症状患者的冠状动脉微血管功能恢复正常。
JACC Case Rep. 2025 Mar 19;30(6 Pt 1):102962. doi: 10.1016/j.jaccas.2024.102962. Epub 2025 Jan 22.
9
Heart failure and microvascular dysfunction: an in-depth review of mechanisms, diagnostic strategies, and innovative therapies.心力衰竭与微血管功能障碍:机制、诊断策略及创新疗法的深入综述
Ann Med Surg (Lond). 2024 Dec 24;87(2):616-626. doi: 10.1097/MS9.0000000000002971. eCollection 2025 Feb.
10
Ischemia with no obstructed coronary arteries and microvascular testing procedures: a review of utility, pharmacotherapy, and current challenges.无阻塞性冠状动脉的缺血与微血管检测程序:效用、药物治疗及当前挑战综述
Front Cardiovasc Med. 2025 Feb 18;12:1523352. doi: 10.3389/fcvm.2025.1523352. eCollection 2025.